These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6124402)

  • 61. NTP Toxicology and Carcinogenesis Studies of Dimethylvinyl Chloride (1-Chloro-2-Methylpropene) (CAS No. 513-37-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1986 Aug; 316():1-238. PubMed ID: 12748737
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Disposition of 14C-alpha-cyclodextrin in germ-free and conventional rats.
    Van Ommen B; De Bie AT; Bär A
    Regul Toxicol Pharmacol; 2004 Jun; 39 Suppl 1():57-66. PubMed ID: 15265616
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of Frog Embryo Teratogenesis Assay-Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin.
    Fort DJ; Bantle JA
    Fundam Appl Toxicol; 1990 May; 14(4):720-33. PubMed ID: 2361573
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Excretion of the principal urinary metabolites of phenytoin and absolute oral bioavailability determined by use of a stable isotope in patients with epilepsy.
    Aliwarga T; Cloyd JC; Goel V; Brundage RC; Marino SE; Leppik IE; Remmel RP
    Ther Drug Monit; 2011 Feb; 33(1):56-63. PubMed ID: 21233690
    [TBL] [Abstract][Full Text] [Related]  

  • 65. NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1986 Aug; 250():1-204. PubMed ID: 12748678
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Urinary dihydrodiol metabolites of phenytoin: high-performance liquid chromatographic assay of diastereomeric composition.
    Maguire JH; Wilson DC
    J Chromatogr; 1985 Aug; 342(2):323-32. PubMed ID: 4055953
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.
    Timchalk C; Smith FA; Bartels MJ
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The elimination of phenytoin in man.
    Eadie MJ; Tyrer JH; Bochner F; Hooper WD
    Clin Exp Pharmacol Physiol; 1976; 3(3):217-24. PubMed ID: 975617
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacokinetics and metabolism of [14C]dichloroacetate in male Sprague-Dawley rats. Identification of glycine conjugates, including hippurate, as urinary metabolites of dichloroacetate.
    James MO; Yan Z; Cornett R; Jayanti VM; Henderson GN; Davydova N; Katovich MJ; Pollock B; Stacpoole PW
    Drug Metab Dispos; 1998 Nov; 26(11):1134-43. PubMed ID: 9806957
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mass fragmentographic determination of diphenylhydantoin and its main metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, in human plasma.
    Hoppel C; Garle M; Elander M
    J Chromatogr; 1976 Jan; 116(1):53-61. PubMed ID: 1245573
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Probabilistic approach to the establishment of maximal content limits of impurities in drug formulations: the case of parenteral diphenylhydantoic acid.
    Manca D; Walker RM; Krishna G; Graziano MJ; Kropko ML
    Regul Toxicol Pharmacol; 1999 Feb; 29(1):1-14. PubMed ID: 10051414
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phenytoin, renal function and renin release.
    Migdal SD; Slick GL; Abu-Hamdan D; McDonald FD
    J Pharmacol Exp Ther; 1980 Nov; 215(2):304-8. PubMed ID: 7003095
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phenytoin metabolic ratio: a putative marker of CYP2C9 activity in vivo.
    Caraco Y; Muszkat M; Wood AJ
    Pharmacogenetics; 2001 Oct; 11(7):587-96. PubMed ID: 11668218
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phenytoin and folic acid interaction: a preliminary report.
    Berg MJ; Fischer LJ; Rivey MP; Vern BA; Lantz RK; Schottelius DD
    Ther Drug Monit; 1983; 5(4):389-94. PubMed ID: 6659012
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dose-dependent effect of cimetidine on phenytoin kinetics.
    Bartle WR; Walker SE; Shapero T
    Clin Pharmacol Ther; 1983 May; 33(5):649-55. PubMed ID: 6839635
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sensitive method for the determination of phenytoin in plasma, and phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in urine by high-performance liquid chromatography.
    Maya MT; Farinha AR; Lucas AM; Morais JA
    J Pharm Biomed Anal; 1992; 10(10-12):1001-6. PubMed ID: 1298355
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Absolute configuration of (+)-5-(o-hydroxyphenyl)-5-phenylhydantoin, the major metabolite of 5,5-diphenylhydantoin in the dog.
    Maguire JH; Butler TC; Dudley KH
    J Med Chem; 1978 Dec; 21(12):1294-7. PubMed ID: 722736
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relationship between serum and brain concentrations of phenytoin in the dog.
    Sanders JE; Yeary RA; Powers JD; de Wet P
    Am J Vet Res; 1979 Apr; 40(4):473-6. PubMed ID: 517820
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Early adventures in drug metabolism: 4. Diphenylhydantoin (phenytoin).
    Glazko AJ
    Ther Drug Monit; 1987 Dec; 9(4):407-15. PubMed ID: 3424406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.